Vera Therapeutics Presents 72-Week Egfr Stabilization and Rapid Hematuria Improvement in Phase 2B Origin Study of Atacicept in Igan at the 61St European Renal Association Congress
Vera Therapeutics在第61届欧洲肾脏协会大会上发布了为期72周的EGFR稳定和快速改善血尿的Igan中Atacept的2B期起源研究